Molecular pathogenesis and current pathology of pulmonary hypertension (Q38676413)

5 September 2017

Molecular pathogenesis and current pathology of pulmonary hypertension (English)

1 reference

5 September 2017

Vinicio A de Jesus Perez

series ordinal

1

1 reference

5 September 2017

22 December 2015

1 reference

5 September 2017

Heart Failure Reviews

1 reference

5 September 2017

21

1 reference

5 September 2017

3

1 reference

5 September 2017

239-257

1 reference

https://scigraph.springernature.com/pub.10.1007/s10741-015-9519-2

5 September 2017

0 references

cites work

Gene-environment interactions in human diseases

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American Coll

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Primary pulmonary hypertension. A national prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

The right ventricle in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Relevant issues in the pathology and pathobiology of pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

How do we measure pathology in PAH (lung and RV) and what does it tell us about the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Pathobiology of pulmonary hypertension. Extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Modern age pathology of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Smooth muscle cell heterogeneity: role of specific smooth muscle cell subpopulations in pulmonary vascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Development of occlusive neointimal lesions in distal pulmonary arteries of endothelin B receptor-deficient rats: a new model of severe pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Targeted therapies in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Therapeutic advances in pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Overexpression of the serine elastase inhibitor elafin protects transgenic mice from hypoxic pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Elafin Reverses Pulmonary Hypertension via Caveolin-1-Dependent Bone Morphogenetic Protein Signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Molecular pathogenesis of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

The pathobiology of pulmonary hypertension. Endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Angiogenesis and pulmonary hypertension: a unique process in a unique disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

The cancer paradigm of severe pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

The complex mural cell: pericyte function in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Pericytes: multitasking cells in the regeneration of injured, diseased, and aged skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Pericytes and adaptive angioplasticity: the role of tumor necrosis factor-like weak inducer of apoptosis (TWEAK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Smooth muscle protein 22alpha-mediated patchy deletion of Bmpr1a impairs cardiac contractility but protects against pulmonary vascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Activation of the Wnt/planar cell polarity pathway is required for pericyte recruitment during pulmonary angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Targeting the adventitial microenvironment in pulmonary hypertension: A potential approach to therapy that considers epigenetic change

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Pulmonary vascular wall stiffness: An important contributor to the increased right ventricular afterload with pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Disruption of PPARγ/β-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-beta-catenin and Wnt-RhoA-Rac1 pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

BMPR2 mutations have short lifetime expectancy in primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Genetics of pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Correction of nonsense BMPR2 and SMAD9 mutations by ataluren in pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Chloroquine in pulmonary arterial hypertension: a new role for an old drug?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Sildenafil potentiates bone morphogenetic protein signaling in pulmonary arterial smooth muscle cells and in experimental pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Altered MicroRNA processing in heritable pulmonary arterial hypertension: an important role for Smad-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Hereditary Haemorrhagic Telangiectasia (HHT): genetic and molecular aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Genetic basis of pulmonary arterial hypertension: current understanding and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Novel mutations in BMPR2, ACVRL1 and KCNA5 genes and hemodynamic parameters in patients with pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Whole-exome sequencing reveals TopBP1 as a novel gene in idiopathic pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

A novel channelopathy in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Whole exome sequencing to identify a novel gene (caveolin-1) associated with human pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Gene expression in BMPR2 mutation carriers with and without evidence of pulmonary arterial hypertension suggests pathways relevant to disease penetrance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Estradiol improves right ventricular function in rats with severe angioproliferative pulmonary hypertension: effects of endogenous and exogenous sex hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

The effects of estrogen on pulmonary artery vasoreactivity and hypoxic pulmonary vasoconstriction: potential new clinical implications for an old hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Bone morphogenetic protein-2 upregulates expression and function of voltage-gated K+ channels in human pulmonary artery smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Functional characterization of voltage-gated K+ channels in mouse pulmonary artery smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Ion channels in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Role of K+ channels in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Two-pore potassium channels in the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Endothelin-1 inhibits background two-pore domain channel TASK-1 in primary human pulmonary artery smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Contractile and electrophysiological properties of pulmonary artery smooth muscle are not altered in TASK-1 knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Upregulated expression of STIM2, TRPC6, and Orai2 contributes to the transition of pulmonary arterial smooth muscle cells from a contractile to proliferative phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Notch Activation of Ca(2+) Signaling in the Development of Hypoxic Pulmonary Vasoconstriction and Pulmonary Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Enhanced store-operated Ca²+ entry and TRPC channel expression in pulmonary arteries of monocrotaline-induced pulmonary hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Inhibition of SOC/Ca2+/NFAT pathway is involved in the anti-proliferative effect of sildenafil on pulmonary artery smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Chronic hypoxia increases TRPC6 expression and basal intracellular Ca2+ concentration in rat distal pulmonary venous smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Molecular and functional significance of Ca(2+)-activated Cl(-) channels in pulmonary arterial smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Role of phosphodiesterases in modulation of BKCa channels in hypertensive pulmonary arterial smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

cAMP activates BKCa channels in pulmonary arterial smooth muscle via cGMP-dependent protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

The Xanthine Derivative KMUP-1 Attenuates Serotonin-Induced Vasoconstriction and K⁺-Channel Inhibitory Activity via the PKC Pathway in Pulmonary Arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Continuous inhalation of carbon monoxide attenuates hypoxic pulmonary hypertension development presumably through activation of BKCa channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Echinacoside induces rat pulmonary artery vasorelaxation by opening the NO-cGMP-PKG-BKCa channels and reducing intracellular Ca2+ levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Dehydroepiandrosterone (DHEA) prevents and reverses chronic hypoxic pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

A proposed mitochondrial-metabolic mechanism for initiation and maintenance of pulmonary arterial hypertension in fawn-hooded rats: the Warburg model of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Targeting energetic metabolism: a new frontier in the pathogenesis and treatment of pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

The role of mitochondria in pulmonary vascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Attenuating endoplasmic reticulum stress as a novel therapeutic strategy in pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Autophagy in pulmonary diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

The role of Nogo and the mitochondria-endoplasmic reticulum unit in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Chloroquine prevents progression of experimental pulmonary hypertension via inhibition of autophagy and lysosomal bone morphogenetic protein type II receptor degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

LC3 as a potential therapeutic target in hypoxia-induced pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Autophagic protein LC3B confers resistance against hypoxia-induced pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Updated Clinical Classification of Pulmonary Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Drugs and toxins-associated pulmonary arterial hypertension: lessons learned and challenges ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Drug-induced pulmonary arterial hypertension: a recent outbreak.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

On the role of serotonin in the pathogenesis of pulmonary hypertension induced by anorectic drugs; an experimental study in the isolated perfused rat lung, II. Fenfluramine, mazindol, mefenorex, phentermine and R 800.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Converging evidence in support of the serotonin hypothesis of dexfenfluramine-induced pulmonary hypertension with novel transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Interdependent serotonin transporter and receptor pathways regulate S100A4/Mts1, a gene associated with pulmonary vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Development of pulmonary arterial hypertension in mice over-expressing S100A4/Mts1 is specific to females.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Pulmonary arterial hypertension seen in methamphetamine abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Mechanisms and pathology of monocrotaline pulmonary toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Cell-based gene transfer to the pulmonary vasculature: Endothelial nitric oxide synthase overexpression inhibits monocrotaline-induced pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

The monocrotaline model of pulmonary hypertension in perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Absence of T cells confers increased pulmonary arterial hypertension and vascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

The Sugen 5416/hypoxia mouse model of pulmonary hypertension revisited: long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

BMPR-II heterozygous mice have mild pulmonary hypertension and an impaired pulmonary vascular remodeling response to prolonged hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Generation of a floxed allele of the mouse BMP type II receptor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Mice expressing BMPR2R899X transgene in smooth muscle develop pulmonary vascular lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Endothelial-to-mesenchymal transition in pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

MicroRNAs: promising therapeutic targets for the treatment of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

MicroRNAs in pulmonary arterial hypertension: pathogenesis, diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

MicroRNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

miR-21 regulates chronic hypoxia-induced pulmonary vascular remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Plexiform vasculopathy of severe pulmonary arterial hypertension and microRNA expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Interleukin-6 overexpression induces pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Role for miR-204 in human pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

The microRNA-130/301 family controls vasoconstriction in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Holding our breath: The emerging and anticipated roles of microRNA in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Epigenetic mechanisms of pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Therapeutic efficacy of valproic acid in a combined monocrotaline and chronic hypoxia rat model of severe pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Suppression of histone deacetylases worsens right ventricular dysfunction after pulmonary artery banding in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Epigenetic repression of bone morphogenetic protein receptor II expression in scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Somatic chromosome abnormalities in the lungs of patients with pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Increased Mutagen Sensitivity and DNA Damage in Pulmonary Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Role for DNA damage signaling in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Autoimmunity and pulmonary hypertension: a perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Krüppel-like factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Endothelial to Mesenchymal Transition Contributes to Endothelial Dysfunction in Pulmonary Arterial Hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

NFAT proteins: key regulators of T-cell development and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

A central role for CD68(+) macrophages in hepatopulmonary syndrome. Reversal by macrophage depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Blocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Neutrophil elastase is produced by pulmonary artery smooth muscle cells and is linked to neointimal lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Serum-induced vascular smooth muscle cell elastolytic activity through tyrosine kinase intracellular signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Epidermal growth factor receptor blockade mediates smooth muscle cell apoptosis and improves survival in rats with pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Investigation of Second Genetic Hits at the BMPR2 Locus as a Modulator of Disease Progression in Familial Pulmonary Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-015-9519-2

Graded pulmonary vascular changes and hemodynamic findings in cases of atrial and ventricular septal defect and patent ductus arteriosus

21 January 2018

1 reference

12 December 2020

Potassium channels in the regulation of pulmonary artery smooth muscle cell proliferation and apoptosis: pharmacotherapeutic implications

1 reference

12 December 2020

A Role for miR-145 in Pulmonary Arterial Hypertension

1 reference

12 December 2020

Interleukin-6 causes mild pulmonary hypertension and augments hypoxia-induced pulmonary hypertension in mice

1 reference

12 December 2020

Pulmonary hypertension associated with long-term inhalation of "crank" methamphetamine

1 reference

12 December 2020

Lung vascular injury from monocrotaline pyrrole, a putative hepatic metabolite.

1 reference

12 December 2020

miR-223 reverses experimental pulmonary arterial hypertension

1 reference

12 December 2020

Microsatellite mutational analysis of endothelial cells within plexiform lesions from patients with familial, pediatric, and sporadic pulmonary hypertension

1 reference

12 December 2020

Pulmonary arterial hypertension

1 reference

12 December 2020

Involvement of serotonin mechanism in methamphetamine-induced chronic pulmonary toxicity in rats

1 reference

12 December 2020

Elastase and cell matrix interactions in the pathobiology of vascular disease.

1 reference

12 December 2020

Targets of anti-endothelial cell antibodies in pulmonary hypertension and scleroderma

1 reference

12 December 2020

Chronic pulmonary hypertension--the monocrotaline model and involvement of the hemostatic system

1 reference

12 December 2020

Pulmonary arterial hypertension

1 reference

12 December 2020

Early pulmonary vascular changes in congenital heart disease studied in biopsy tissue.

1 reference

12 December 2020

Impact of TASK-1 in Human Pulmonary Artery Smooth Muscle Cells

1 reference

12 December 2020

Mechanisms of structural remodeling in chronic pulmonary hypertension

1 reference

12 December 2020

Appetite suppressants and cardiac valvulopathy. Current clinical perspectives

1 reference

12 December 2020

EVE and beyond, retro and prospective insights

1 reference

12 December 2020

Pulmonary hemodynamics modify the rat pulmonary artery response to injury. A neointimal model of pulmonary hypertension

1 reference

12 December 2020

Increased pericyte coverage mediated by endothelial-derived fibroblast growth factor-2 and interleukin-6 is a source of smooth muscle-like cells in pulmonary hypertension

1 reference

12 December 2020

A molecular dissection of lymphocyte unresponsiveness induced by sustained calcium signalling.

1 reference

12 December 2020

Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension

1 reference

12 December 2020

Interaction of interleukin-6 and the BMP pathway in pulmonary smooth muscle

1 reference

12 December 2020

Rodent models of group 1 pulmonary hypertension.

1 reference

12 December 2020

The pathology of hypertensive pulmonary vascular disease; a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects

1 reference

12 December 2020

Reactivation of gammaHV68 induces neointimal lesions in pulmonary arteries of S100A4/Mts1-overexpressing mice in association with degradation of elastin

1 reference

12 December 2020

Proliferative changes in the pulmonary arterial wall during short-term hyperoxic injury to the lung

1 reference

12 December 2020

Loss of bone morphogenetic protein receptor 2 is associated with abnormal DNA repair in pulmonary arterial hypertension

1 reference

12 December 2020

Formation of plexiform lesions in experimental severe pulmonary arterial hypertension

1 reference

12 December 2020

Elastase and the pathobiology of unexplained pulmonary hypertension

1 reference

12 December 2020

10.1007/S10741-015-9519-2

Identifiers

DOI

1 reference

5 September 2017

1 reference

PubMed ID

26694808